The company recently released an RUO RNA extraction kit, and plans to launch a liquid biopsy pan-cancer test and disease-specific NGS panels later this year.
A 400-sample retrospective analysis in invasive breast cancer will inform a basket trial that the Ontario Institute for Cancer Research hopes to soon launch.
Harvard researchers found that variants previously classified as pathogenic were in fact benign, disproportionately affecting patients of African ancestry.
The technique will use optical maps and barcodes in order to generate long scaffolds from short-read sequencing technology.
The Sydney-based genomics center is implementing diagnostic sequencing pipelines and figuring out best practices for incorporating genomics into healthcare.
In Science this week: role for epigenetic in neuronal excitability, and more.
The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.
Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.
A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.